A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07845487. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Induction and Maintenance Therapy With PALI-2108 in Participants With Moderately to Severely Active Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe it is, and how the body responds to it.
Study identification
- NCT ID
- NCT07845487
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 204 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 28, 2026 (Actual)
- Primary completion
- Oct 2027 (Estimated)
- Completion
- Jun 2028 (Estimated)
- Last update posted
- Nov 12, 2026
2026 – 2028
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US-022 | Sun City | Arizona | 85351 | Recruiting |
| Site US-018 | San Diego | California | 92103 | Recruiting |
| Site US-028 | Bristol | Connecticut | 06010 | Recruiting |
| Site US-026 | Orlando | Florida | 32825 | Recruiting |
| Site US-005 | Des Plaines | Illinois | 60016 | Recruiting |
| Site US-007 | Glenview | Illinois | 60026 | Recruiting |
| Site US-020 | Gurnee | Illinois | 60031 | Recruiting |
| Site US-008 | Baton Rouge | Louisiana | 70809 | Recruiting |
| Site US-011 | Mandeville | Louisiana | 70471 | Recruiting |
| Site US-010 | Tupelo | Mississippi | 38801 | Recruiting |
| Site US-006 | St Louis | Missouri | 63141 | Recruiting |
| Site US-014 | Clifton | New Jersey | 07013 | Recruiting |
| Site US-002 | Albany | New York | 12206 | Recruiting |
| Site US-016 | Rochester | New York | 14618 | Recruiting |
| Site US-025 | Brunswick | Ohio | 44212 | Recruiting |
| Site US-023 | Dayton | Ohio | 45415 | Recruiting |
| Site US-027 | Westlake | Ohio | 44145 | Recruiting |
| Site US-019 | Providence | Rhode Island | 02905 | Recruiting |
| Site US-003 | Cordova | Tennessee | 38018 | Recruiting |
| Site US-024 | Garland | Texas | 75044 | Recruiting |
| Site US-009 | Georgetown | Texas | 78628 | Recruiting |
| Site US-030 | Houston | Texas | 77024 | Recruiting |
| Site US-015 | Lubbock | Texas | 79424 | Recruiting |
| Site US-017 | Mansfield | Texas | 760063 | Recruiting |
| Site US-001 | Southlake | Texas | 76092 | Recruiting |
| Site US-004 | Tyler | Texas | 75701 | Recruiting |
| Site US-013 | Richmond | Virginia | 23229 | Recruiting |
| Site US-021 | Bellevue | Washington | 98004 | Recruiting |
| Site US-029 | Tacoma | Washington | 98405 | Recruiting |
| Site US-012 | Milwaukee | Wisconsin | 53215 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07845487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.